Overall, our data reveal that FABP7 plays an important role not only in tumor-intrinsic metabolic and oncogenic processes but also in shaping the tumor’s immune landscape, suggesting that targeting FABP7 could provide therapeutic strategies for modulating both tumor growth and immune evasion in brain cancers. This evidence concerns the gene FABP7 and neoplasm.